139 related articles for article (PubMed ID: 34153848)
1. Design BH3 domain fusion protein as targeting pro-apoptotic self-assembling nanoparticles.
Shuai Z; Zheng Y; Jiang J; Yu R; Zhang C
Biomed Pharmacother; 2021 Sep; 141():111825. PubMed ID: 34153848
[TBL] [Abstract][Full Text] [Related]
2. Design of integrin α
Lv X; Zhang C; Shuaizhen Q; Yu R; Zheng Y
Biomed Pharmacother; 2020 Aug; 128():110236. PubMed ID: 32447209
[TBL] [Abstract][Full Text] [Related]
3. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
4. BH3 Mimetic Sensitivity of Colorectal Cancer Cell Lines in Correlation with Molecular Features Identifies Predictors of Response.
Zhang L; Ramesh P; Steinmetz M; Medema JP
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917026
[TBL] [Abstract][Full Text] [Related]
5. Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET.
Liu Q; Leber B; Andrews DW
Cell Cycle; 2012 Oct; 11(19):3536-42. PubMed ID: 22895112
[TBL] [Abstract][Full Text] [Related]
6. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
Tomek M; Akiyama T; Dass CR
J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
[TBL] [Abstract][Full Text] [Related]
7. B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.
Renault TT; Elkholi R; Bharti A; Chipuk JE
J Biol Chem; 2014 Sep; 289(38):26481-26491. PubMed ID: 25096574
[TBL] [Abstract][Full Text] [Related]
8. RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm.
Kitagawa T; Kosuge H; Uchida M; Iida Y; Dalman RL; Douglas T; McConnell MV
J Magn Reson Imaging; 2017 Apr; 45(4):1144-1153. PubMed ID: 27689830
[TBL] [Abstract][Full Text] [Related]
9. Extending Half Life of H-Ferritin Nanoparticle by Fusing Albumin Binding Domain for Doxorubicin Encapsulation.
Wang C; Zhang C; Li Z; Yin S; Wang Q; Guo F; Zhang Y; Yu R; Liu Y; Su Z
Biomacromolecules; 2018 Mar; 19(3):773-781. PubMed ID: 29328653
[TBL] [Abstract][Full Text] [Related]
10. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
11. High hydrostatic pressure encapsulation of doxorubicin in ferritin nanocages with enhanced efficiency.
Wang Q; Zhang C; Liu L; Li Z; Guo F; Li X; Luo J; Zhao D; Liu Y; Su Z
J Biotechnol; 2017 Jul; 254():34-42. PubMed ID: 28591619
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737.
Stauffer SR
Curr Top Med Chem; 2007; 7(10):961-5. PubMed ID: 17508927
[TBL] [Abstract][Full Text] [Related]
13. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
[TBL] [Abstract][Full Text] [Related]
14. The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain.
Tong Y; Yang Q; Vater C; Venkatesh LK; Custeau D; Chittenden T; Chinnadurai G; Gourdeau H
Mol Cancer Ther; 2001 Dec; 1(2):95-102. PubMed ID: 12467227
[TBL] [Abstract][Full Text] [Related]
15. Cargo loading within ferritin nanocages in preparation for tumor-targeted delivery.
Zhang J; Cheng D; He J; Hong J; Yuan C; Liang M
Nat Protoc; 2021 Oct; 16(10):4878-4896. PubMed ID: 34497386
[TBL] [Abstract][Full Text] [Related]
16. Assembling BH3-mimic peptide into a nanocluster to target intracellular Bcl2 towards the apoptosis induction of cancer cell.
Zhang X; Gao R; Yan H; Zhao Z; Zhang J; You W
Nanotechnology; 2021 Dec; 33(8):. PubMed ID: 34261054
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry.
Choi YB; Sandford G; Nicholas J
PLoS Pathog; 2012; 8(6):e1002748. PubMed ID: 22685405
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2-regulated apoptosis: mechanism and therapeutic potential.
Adams JM; Cory S
Curr Opin Immunol; 2007 Oct; 19(5):488-96. PubMed ID: 17629468
[TBL] [Abstract][Full Text] [Related]
19. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
20. Enhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size.
Cai Y; Cao C; He X; Yang C; Tian L; Zhu R; Pan Y
Int J Nanomedicine; 2015; 10():2619-34. PubMed ID: 25878496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
